Cocrystal Pharma (COCP)

Influenza Trial To Extend Enrollment, Norovirus Trial Data Expected in 1H25


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
January 6, 2025
Report ID: 27220
Already Registered?
Click the Get Report button to login and view the full report, with price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Register Now to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Cocrystal Pharma Inc.
Cocrystal Pharma Inc.
Healthcare
Biotechnology
Ticker
COCP
Current Price
$2.4229 0.66%
Market Cap
$24.7M
Price Target
Refer to Report
Volume
5.3K
52wk Range
$1.325 - $3.26
© 2018-2025 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.